- Report
- October 2024
- 138 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2018
- 11 Pages
Global
From €9101EUR$10,000USD£7,802GBP
Lovaza is a market of cardiovascular drugs used to treat high triglyceride levels. It is a prescription medication that contains a combination of omega-3 fatty acids, which are essential fatty acids that cannot be produced by the body. Lovaza is used to reduce the risk of heart attack and stroke in people with high triglyceride levels. It is also used to reduce the risk of developing pancreatitis in people with high triglyceride levels. Lovaza is available in capsule form and is taken orally.
The Lovaza market is composed of a variety of companies that produce and distribute the drug. These companies include GlaxoSmithKline, Amarin Corporation, and Par Pharmaceuticals. Other companies involved in the Lovaza market include Apotex, Mylan, and Teva Pharmaceuticals. These companies are responsible for the production, distribution, and marketing of Lovaza. Show Less Read more